Affiliation:
1. Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri 63110-1093.
Abstract
Processing of the hepatitis C virus (HCV) H strain polyprotein yields at least nine distinct cleavage products: NH2-C-E1-E2-NS2-NS3-NS4A-NS4B-NS5A-NS5B-CO OH. As described in this report, site-directed mutagenesis and transient expression analyses were used to study the role of a putative serine proteinase domain, located in the N-terminal one-third of the NS3 protein, in proteolytic processing of HCV polyproteins. All four cleavages which occur C terminal to the proteinase domain (3/4A, 4A/4B, 4B/5A, and 5A/5B) were abolished by substitution of alanine for either of two predicted residues (His-1083 and Ser-1165) in the proteinase catalytic triad. However, such substitutions have no observable effect on cleavages in the structural region or at the 2/3 site. Deletion analyses suggest that the structural and NS2 regions of the polyprotein are not required for the HCV NS3 proteinase activity. NS3 proteinase-dependent cleavage sites were localized by N-terminal sequence analysis of NS4A, NS4B, NS5A, and NS5B. Sequence comparison of the residues flanking these cleavage sites for all sequenced HCV strains reveals conserved residues which may play a role in determining HCV NS3 proteinase substrate specificity. These features include an acidic residue (Asp or Glu) at the P6 position, a Cys or Thr residue at the P1 position, and a Ser or Ala residue at the P1' position.
Publisher
American Society for Microbiology
Subject
Virology,Insect Science,Immunology,Microbiology
Reference94 articles.
1. Alter H. J. B. W. Jett A. J. Polito P. Farci J. C. Melpolder J. W. Shih Y. Shimizu and R. H. Purcell. 1991. Analysis of the role of hepatitis C virus in transfusion-associated hepatitis p. 396-402. In F. B. Hollinger S. M. Lemon and H. S. Margolis (ed.) Viral hepatitis and liver disease. The Williams & Wilkins Co. Baltimore.
2. Alter H. J. R. H. Purcell P. V. Holland and H. Popper. 1978. Transmissible agent in non-A non-B hepatitis. Lancet i:459-463.
3. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A non-B hepatitis;Alter H. J.;N. Engl. J. Med.,1989
4. Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection;Alter M. J.;JAMA,1990
5. Amberg S. M. and C. M. Rice. Unpublished data.
Cited by
589 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献